Skip to main content

Oxford Physicist - “We should stop running away from radiation”

Over at the BBC, Wade Allison, nuclear and medical physicist at the University of Oxford, helps put radiation in perspective:

More than 10,000 people have died in the Japanese tsunami and the survivors are cold and hungry. But the media concentrate on nuclear radiation from which no-one has died - and is unlikely to.

Nuclear radiation at very high levels is dangerous, but the scale of concern that it evokes is misplaced. Nuclear technology cures countless cancer patients every day - and a radiation dose given for radiotherapy in hospital is no different in principle to a similar dose received in the environment.

People worry about radiation because they cannot feel it. However, nature has a solution - in recent years it has been found that living cells replace and mend themselves in various ways to recover from a dose of radiation.

These clever mechanisms kick in within hours and rarely fail, except when they are overloaded - as at Chernobyl, where most of the emergency workers who received a dose greater than 4,000 mSv over a few hours died within weeks.

However, patients receiving a course of radiotherapy usually get a dose of more than 20,000 mSv to vital healthy tissue close to the treated tumour. This tissue survives only because the treatment is spread over many days giving healthy cells time for repair or replacement.

In this way, many patients get to enjoy further rewarding years of life, even after many vital organs have received the equivalent of more than 20,000 years' dose at the above internationally recommended annual limit …

There’s much more from the professor at the BBC. Be sure to stop by and see what he says about the radiation from Fukushima and if he would accept used fuel buried under his house.

Comments

Popular posts from this blog

Fluor Invests in NuScale

You know, it’s kind of sad that no one is willing to invest in nuclear energy anymore. Wait, what? NuScale Power celebrated the news of its company-saving $30 million investment from Fluor Corp. Thursday morning with a press conference in Washington, D.C. Fluor is a design, engineering and construction company involved with some 20 plants in the 70s and 80s, but it has not held interest in a nuclear energy company until now. Fluor, which has deep roots in the nuclear industry, is betting big on small-scale nuclear energy with its NuScale investment. "It's become a serious contender in the last decade or so," John Hopkins, [Fluor’s group president in charge of new ventures], said. And that brings us to NuScale, which had run into some dark days – maybe not as dark as, say, Solyndra, but dire enough : Earlier this year, the Securities Exchange Commission filed an action against NuScale's lead investor, The Michael Kenwood Group. The firm "misap...

Wednesday Update

From NEI’s Japan micro-site: NRC, Industry Concur on Many Post-Fukushima Actions Industry/Regulatory/Political Issues • There is a “great deal of alignment” between the U.S. Nuclear Regulatory Commission and the industry on initial steps to take at America’s nuclear energy facilities in response to the nuclear accident in Japan, Charles Pardee, the chief operating officer of Exelon Generation Co., said at an agency briefing today. The briefing gave stakeholders an opportunity to discuss staff recommendations for near-term actions the agency may take at U.S. facilities. PowerPoint slides from the meeting are on the NRC website. • The International Atomic Energy Agency board has approved a plan that calls for inspectors to evaluate reactor safety at nuclear energy facilities every three years. Governments may opt out of having their country’s facilities inspected. Also approved were plans to maintain a rapid response team of experts ready to assist facility operators recoverin...

Nuclear Utility Moves Up in Credit Ratings, Bank is "Comfortable with Nuclear Strategy"

Some positive signs that nuclear utilities can continue to receive positive ratings even while they finance new nuclear plants for the first time in decades: Wells Fargo upgrades SCANA to Outperform from Market Perform Wells analyst says, "YTD, SCG shares have underperformed the Regulated Electrics (total return +2% vs. +9%). Shares trade at 11.3X our 10E EPS, a modest discount to the peer group median of 11.8X. We view the valuation as attractive given a comparatively constructive regulatory environment and potential for above-average long-term EPS growth prospects ... Comfortable with Nuclear Strategy. SCG plans to participate in the development of two regulated nuclear units at a cost of $6.3B, raising legitimate concerns regarding financing and construction. We have carefully considered the risks and are comfortable with SCG’s strategy based on a highly constructive political & regulatory environment, manageable financing needs stretched out over 10 years, strong partners...